Dr. Amy Degnim, M.D.

Claim this profile

Mayo Clinic

Studies Skin Cancer
Studies Vulval Intraepithelial Neoplasia
2 reported clinical trials
2 drugs studied

Area of expertise

1Skin Cancer
Amy Degnim, M.D. has run 2 trials for Skin Cancer. Some of their research focus areas include:
Stage I
Stage II
HER2 positive
2Vulval Intraepithelial Neoplasia
Amy Degnim, M.D. has run 2 trials for Vulval Intraepithelial Neoplasia. Some of their research focus areas include:
Stage I
Stage II
HER2 positive

Affiliated Hospitals

Image of trial facility.
Mayo Clinic
Image of trial facility.
Mayo Clinic In Rochester

Clinical Trials Amy Degnim, M.D. is currently running

Image of trial facility.

H2NVAC Vaccine

for Breast Cancer

This trial studies the H2NVAC vaccine, which aims to boost the immune system to fight breast cancer in patients with HER2-expressing DCIS. The vaccine helps the body recognize and attack cancer cells by targeting the HER2 protein. H2NVAC is a vaccine targeting the HER2 protein, similar to other HER2/neu vaccines being tested for their ability to elicit immune responses against breast cancer.
Recruiting1 award Phase 122 criteria

More about Amy Degnim, M.D.

Clinical Trial Related5 years of experience running clinical trials · Led 2 trials as a Principal Investigator · 1 Active Clinical Trial
Treatments Amy Degnim, M.D. has experience with
  • Tamoxifen
  • Multi-epitope HER2 Peptide Vaccine H2NVAC
Breakdown of trials Amy Degnim, M.D. has run
Skin Cancer
Vulval Intraepithelial Neoplasia
Lobular Carcinoma in Situ
Lobular Carcinoma
Mammary Gland Hyperplasia

Other Doctors you might be interested in

Aminah Jatoi, M.D.Mayo Clinic in Rochester
David A. Woodrum, M.D., Ph.D.Mayo Clinic in Minnesota
Maciej Mrugala, MDMayo Clinic

Frequently asked questions

Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Amy Degnim, M.D. specialize in?
Amy Degnim, M.D. focuses on Skin Cancer and Vulval Intraepithelial Neoplasia. In particular, much of their work with Skin Cancer has involved Stage I patients, or patients who are Stage II.
Is Amy Degnim, M.D. currently recruiting for clinical trials?
Yes, Amy Degnim, M.D. is currently recruiting for 1 clinical trial in Rochester Minnesota. If you're interested in participating, you should apply.
Are there any treatments that Amy Degnim, M.D. has studied deeply?
Yes, Amy Degnim, M.D. has studied treatments such as Tamoxifen, Multi-epitope HER2 Peptide Vaccine H2NVAC.
What is the best way to schedule an appointment with Amy Degnim, M.D.?
Apply for one of the trials that Amy Degnim, M.D. is conducting.
What is the office address of Amy Degnim, M.D.?
The office of Amy Degnim, M.D. is located at: Mayo Clinic, Rochester, Minnesota 55905 United States. This is the address for their practice at the Mayo Clinic.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top